MedPath

BioDelivery Sciences International, Inc.

BioDelivery Sciences International, Inc. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
1997-01-01
Employees
200
Market Cap
-
Website
http://www.bdsi.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

FDA:3

Drug Approvals

BELBUCA

Approval Date
Dec 21, 2023
FDA

SYMPROIC

Approval Date
Dec 23, 2022
FDA

ELYXYB - celecoxib

Approval Date
Oct 1, 2021
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.